//2019 INTERNATIONAL PANCREATIC CANCER FORUM

2019 INTERNATIONAL PANCREATIC CANCER FORUM

Advanced Pancreatic cancer (PC) is well-known for high mortality and low survival rate. Among existing treatments and regimens, FOLFIRINOX is one of the primary and dominant regimens for clinical use. This forum invites physicians to share valuable experience in FOLFIRINOX application.

Information

2019 INTERNATIONAL PANCREATIC CANCER FORUM

Guests

Moderator

Dr. Li-Tzong Chen

Dr. Li-Tzong Chen

Chairman of Taiwan Oncology Society
Director of National Institute of Cancer Research, National Health Research Institute, Taiwan

Professional Experiences:
Distinguished Investigator, National Institute of Cancer Research, National Health Research Institutes, Taiwan
Professor, Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
Adjunct Professor, Internal Medicine, Medical School, National Cheng Kung University, Tainan, Taiwan
Adjunct Professor, College of Medical Technology, Taipei Medical University, Taipei, Taiwan
Adjunct Professor, Institute of Clinical Pharmacy and Pharmaceutical Science, National Cheng Kung University, Tainan, Taiwan

Specialities: Medical Oncology, Gastroenterology, Experimental therapy and Translational Research

Moderator

Dr. Ta-Sen Yeh

Dr. Ta-Sen Yeh

Chairman of Taiwan Pancreas Society
Director of Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taiwan

Professional Experiences:
Deputy Director of Department of Surgery, Linkou Chang Gung Memorial Hospital, Taiwan
President of Research and Review Committee, Department of Medical Research and Development, Chang Gung Memorial Hospital, Taiwan
Researcher of Department of Surgery, Beaujon Hospital, Paris, France

Specialities: Gastrointestinal surgery, Biliary and laparoscopic surgery, da Vinci Surgery

Speaker (Taiwan)

Li-Yuan Bai, M.D., M.M.S., Ph.D.

Li-Yuan Bai, M.D., M.M.S., Ph.D.

Director, Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan
Deputy Director, Clinical Trial Center, China Medical University Hospital
Professor, China Medical University

Professional Experiences:
Ph.D., Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan
Visiting scholar at College of Pharmacy, The Ohio State University, Columbus, OH, USA

Speaker (Korea)

Hong Jae Chon, M.D., Ph.D.

Hong Jae Chon, M.D., Ph.D.

Associate Professor, Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea

Professional Experiences:
Co-Director, Laboratory of Tumor Vasculature and Microenvironment, CHA University, Pangyo, Seongnam, Korea
Assistant Professor, Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
PhD, Yonsei Graduate School, Seoul, College of Medicine, Korea

Speaker (US)

Philip Agop Philip, M.D., Ph.D., F.R.C.P., F.A.B.C.

Philip Agop Philip, M.D., Ph.D., F.R.C.P., F.A.B.C.

Professor of Oncology, Pharmacology and Medicine
Kathryn Cramer Endowed Chair in Cancer Research
Vice President of Medical Affairs
Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine

Professional Experiences:
Chair, GI Committee, SWOG
Member, Scientific Committee: ESMO 21st Annual World Congress on Gastrointestinal Cancer
Member, Department of Oncology Review Committee, School of Medicine
Member, Metastatic Pancreatic Cancer Guideline Panel, ASCO
Ph.D. in Clinical Pharmacology and Pharmacogenetics, University of London, Guy’s Hospital Medical School, London, UK

Speaker (Hungary)

Zsuzsanna Pápai , M.D.

Zsuzsanna Pápai , M.D.

Head of Oncology Department, Medical Centre-Hungarian Defence Forces, Budapest, Hungary

Professional Experiences:
Head of Oncology Department, National Medical Center, Budapest, Hungary
Assistant Professor of Clinical Oncology, National Institute of Oncology, Budapest, Hungary
Hungarian Society for Internal Disease
Hungarian Society for Oncology
Associate editor  of the Journal of Hungarian Oncology
Member of EORTC Soft Tissue and Bone Sarcoma Group

Speaker (France)

Jean-Philippe Metges, M.D.

Jean-Philippe Metges, M.D.

Associate Professor & Oncology Physician,
Medical Coordinator of Regional Cancer Center of Brittany,
Institute of Oncology and Hematology, Brest CHRU, France

Professional Experiences:
Senior Resident Physician of the Department of Radiotherapy, Institute of Gustave Roussy Villejuif (Prof. François Eschwege)
Former Assistant of Medical Oncology of the University Hospital of Brest, Service of medical oncology and radiotherapy (Prof. J.P. Labat)
CCA of Hepato-gastroenterology in charge of Digestive Oncology

Attendee

Suitable for attendees include attending physicians, residents, clinically relevant professionals and researchers.

Medical education credits reserved.

  • Taiwan Oncology Society: 10 credits
  • Taiwan Clinical Oncology Society: 2 credits
  • Taiwan Surgical Association: 10 credits
  • The Digestive Endoscopy Society of Taiwan: Type B, 1 credit
  • The Gastroenterological Society of Taiwan: Type B, 2 credits
  • Taiwan Surgical Society of Gastroenterology: Type B, 3 credits
  • Taiwan Association for Endoscopic Surgery: 10 credits
  • Taiwan Society of Ultrasound in Medicine: 5 credits
  • Taiwan Society for Therapeutic Radiology and Oncology: 2 credits

Registration

Registration (En)
Please fill in the real name
E.g. Hospital, Institute
Please fill in "None" if there is no fully suitable answer.

Notes

  • Registration deadline: 07/24/2019.
  • The success of registration shall and only be confirmed by email within 3 working days after registration.
  • Due to quota limitation, the organizer may close the online registration at any time and retain final right of registration qualification.
  • The organizer reserves the right for agenda and speaker modification due to any reasons of force majeure.
  • Contact: 02-2760-3688 #2854  Ms. Yu-Sion Siao
2019-07-19T00:50:24+08:00June 14th, 2019|Events|